Clinical meaning
The nurse practitioner evaluates and manages Sjögren syndrome through advanced understanding of immune system pathophysiology, autoimmune mechanisms, and immunomodulatory pharmacotherapy. Assessment includes focused history (pattern of organ involvement, chronicity, triggers, family history of autoimmune disease, medication exposure, infectious disease history), physical examination targeting commonly affected organs (skin, joints, kidneys, lungs, nervous system, eyes, salivary and lacrimal glands), and interpretation of immunological studies (ANA with pattern, specific autoantibodies, complement levels, inflammatory markers, immunoglobulin levels, and disease-specific serologies). The clinician applies classification criteria for autoimmune diseases, differentiates primary from secondary autoimmune phenomena, and recognizes overlap syndromes. Pharmacotherapy ranges from anti-inflammatory agents (NSAIDs, corticosteroids) to immunosuppressive and immunomodulatory therapies (hydroxychloroquine, methotrexate, azathioprine, mycophenolate, cyclophosphamide, biologics including TNF inhibitors, rituximab, and belimumab), with understanding of mechanism of action, monitoring requirements, and infection prophylaxis. The clinician screens for and manages complications of both the disease and its treatment, coordinates multidisciplinary care with rheumatology, nephrology, pulmonology, and dermatology as indicated, and provides patient education on disease self-management, medication adherence, and when to seek urgent care.